BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27914947)

  • 1. Synthesis and binding monitoring of a new nanomolar PAMAM-based matrix metalloproteinases inhibitor (MMPIs).
    Cerofolini L; Baldoneschi V; Dragoni E; Storai A; Mamusa M; Berti D; Fragai M; Richichi B; Nativi C
    Bioorg Med Chem; 2017 Jan; 25(2):523-527. PubMed ID: 27914947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome.
    Richichi B; Baldoneschi V; Burgalassi S; Fragai M; Vullo D; Akdemir A; Dragoni E; Louka A; Mamusa M; Monti D; Berti D; Novellino E; De Rosa G; Supuran CT; Nativi C
    Chemistry; 2016 Jan; 22(5):1714-21. PubMed ID: 26692423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a dendrimer with a matrix metalloproteinase-responsive fluorescence probe and a tumor-homing peptide for metastatic tumor cell imaging in the lymph node.
    Nagai K; Sato T; Kojima C
    Bioorg Med Chem Lett; 2021 Feb; 33():127726. PubMed ID: 33316406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma.
    Khalil HH; Osman HA; Teleb M; Darwish AI; Abu-Serie MM; Khattab SN; Haiba NS
    ChemMedChem; 2021 Dec; 16(24):3701-3719. PubMed ID: 34547831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
    Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P
    Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.
    Agamennone M; Belov DS; Laghezza A; Ivanov VN; Novoselov AM; Andreev IA; Ratmanova NK; Altieri A; Tortorella P; Kurkin AV
    ChemMedChem; 2016 Sep; 11(17):1892-8. PubMed ID: 27418256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).
    Yuan H; Lu W; Wang L; Shan L; Li H; Huang J; Sun Q; Zhang W
    Eur J Med Chem; 2013 Apr; 62():148-57. PubMed ID: 23353736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.
    Nanjan P; Nambiar J; Nair BG; Banerji A
    Bioorg Med Chem; 2015 Jul; 23(13):3781-7. PubMed ID: 25907368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors.
    Beutel B; Song J; Konken CP; Korpos E; Schinor B; Gerwien H; Vidyadharan R; Burmeister M; Li L; Haufe G; Sorokin L
    Bioconjug Chem; 2018 Nov; 29(11):3715-3725. PubMed ID: 30277751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
    Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A
    J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
    Zhang H; Wang X; Mao J; Huang Y; Xu W; Duan Y; Zhang J
    Bioorg Med Chem; 2018 Aug; 26(15):4363-4374. PubMed ID: 30093347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity.
    Rocchi D; Blázquez-Barbadillo C; Agamennone M; Laghezza A; Tortorella P; Vicente-Zurdo D; Rosales-Conrado N; Moyano P; Pino JD; González JF; Menéndez JC
    Eur J Med Chem; 2021 Jan; 210():113061. PubMed ID: 33310289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.
    Sjøli S; Nuti E; Camodeca C; Bilto I; Rossello A; Winberg JO; Sylte I; Adekoya OA
    Eur J Med Chem; 2016 Jan; 108():141-153. PubMed ID: 26638045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost.
    Liu H; Wang H; Yang W; Cheng Y
    J Am Chem Soc; 2012 Oct; 134(42):17680-7. PubMed ID: 23050493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase.
    Mendes DE; Wong-On-Wing A; Berkman CE
    J Enzyme Inhib Med Chem; 2016; 31(1):167-71. PubMed ID: 25815671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.
    Beutel B; Daniliuc CG; Riemann B; Schäfers M; Haufe G
    Bioorg Med Chem; 2016 Feb; 24(4):902-9. PubMed ID: 26810711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors.
    Yamahana H; Komiya Y; Takino T; Endo Y; Yamada H; Asada C; Uto Y
    Chem Pharm Bull (Tokyo); 2021; 69(10):1017-1028. PubMed ID: 34602570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids.
    Behrends M; Wagner S; Kopka K; Schober O; Schäfers M; Kumbhar S; Waller M; Haufe G
    Bioorg Med Chem; 2015 Jul; 23(13):3809-18. PubMed ID: 25921268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17).
    Qiu Z; Yan M; Li Q; Liu D; Van den Steen PE; Wang M; Opdenakker G; Hu J
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):533-40. PubMed ID: 21827363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of ferulic Acid amides as selective matrix metalloproteinase inhibitors.
    Shi ZH; Li NG; Shi QP; Tang H; Tang YP; Li W; Yin L; Yang JP; Duan JA
    Med Chem; 2013 Nov; 9(7):947-54. PubMed ID: 23061601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.